Julio Wainstein

Medicine & Life Sciences

1. Type 2 Diabetes Mellitus 100%
2. Glucose 49%
3. Insulin 36%
4. Breakfast 33%
5. Hypoglycemia 31%
6. Blood Glucose 31%
7. Placebos 28%
8. Meals 28%
9. Hyperglycemia 21%
10. Type 1 Diabetes Mellitus 18%
11. Randomized Controlled Trials 17%
12. Sitagliptin Phosphate 17%
13. Internal Medicine 16%
14. Hypoglycemic Agents 16%
15. Therapeutics 16%
16. Weight Loss 15%
17. Fasting 15%
18. Hospitalization 15%
19. Diabetes Mellitus 15%
20. Safety 14%
21. Gastroparesis 12%
22. Population 12%
23. Chronic Renal Insufficiency 11%
24. Lunch 11%
25. Diet 10%
26. Serum 10%
27. Mortality 10%
28. olive extract 10%
29. Life Style 9%
30. Mitochondrial DNA 9%
31. 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol 9%
32. Diabetes Complications 9%
33. Circadian Clocks 9%
34. Insulin Glargine 8%
35. Israel 8%
36. Acarbose 8%
37. Glucagon-Like Peptide 1 8%
38. Elderly 8%
39. Whey Proteins 8%
40. N,N-dimethylarginine 8%
41. Length of Stay 8%
42. TRPV1 receptor 8%
43. Incidence 7%
44. C-Peptide 7%
45. Energy Intake 7%
46. Genes 7%
47. Functional Food 7%
48. Metformin 7%
49. Blood Pressure 7%
50. LY3298176 7%